Cefuroxime Dosing in Hemodialysis Patients
For adult patients undergoing intermittent hemodialysis, administer cefuroxime 750 mg every 24 hours, with an additional 750 mg dose given immediately after each dialysis session 1.
Dosing Rationale
The FDA-approved labeling for cefuroxime provides explicit guidance for hemodialysis patients. Since cefuroxime is dialyzable (approximately 86% of total clearance occurs through hemofiltration 2), the standard dosing interval must be extended from every 8 hours to every 24 hours in patients with creatinine clearance <10 mL/min 1.
Key Dosing Principles
- Base dose: 750 mg every 24 hours for patients with creatinine clearance <10 mL/min
- Post-dialysis supplementation: An additional 750 mg dose must be administered at the end of each dialysis session to replace drug removed during dialysis 1
- Timing: The supplemental dose should be given immediately after dialysis is completed to avoid premature drug removal and ensure adequate serum concentrations between dialysis sessions
Pharmacokinetic Considerations
Cefuroxime exhibits significant removal during hemodialysis. Research demonstrates that during intermittent hemofiltration, the terminal half-life of cefuroxime is dramatically shortened to 1.6 hours (compared to 21.7 hours in anuric patients not receiving dialysis), with hemofiltration removing approximately 63% of the administered dose 2. This substantial dialytic clearance necessitates post-dialysis supplementation to maintain therapeutic concentrations.
The standard half-life of cefuroxime in patients with normal renal function is approximately 80 minutes, but this extends significantly in renal impairment 1. Without dose adjustment, drug accumulation and potential toxicity can occur.
Clinical Monitoring
While the FDA labeling provides clear dosing guidance, therapeutic drug monitoring is not routinely required for cefuroxime in hemodialysis patients, unlike aminoglycosides or vancomycin. However, clinical response should be monitored, and dosing may need adjustment based on:
- Infection severity: For severe or life-threatening infections, consider increasing the base dose to 1.5 grams every 24 hours with appropriate post-dialysis supplementation
- Pathogen susceptibility: Ensure the causative organism's MIC is within the susceptible range for the chosen dose
- Dialysis schedule: The regimen assumes thrice-weekly intermittent hemodialysis; adjustments may be needed for different dialysis frequencies
Important Caveats
Do not reduce the milligram dose below 750 mg even in renal failure, as cefuroxime exhibits concentration-dependent bactericidal activity. Smaller doses may compromise efficacy 1. The adjustment should be made by extending the dosing interval, not by reducing the individual dose amount.
For patients on continuous renal replacement therapy (CRRT) rather than intermittent hemodialysis, this dosing regimen does not apply. CRRT requires different dosing considerations due to continuous drug removal.